Rising stars

These annual EAS prizes for young scientists are intended to recognize distinction shown by publications that contribute to the advancement of knowledge in the field of atherosclerosis and linked metabolic disturbances.

Paolo Zanoni

Zurich, Switzerland

Paolo Zanoni was born in 1984 in Mantova, Italy. He graduated in Human medicine at the University of Modena and Reggio Emilia in 2009 under the supervision of Prof. Sebastiano Calandra Buonaura, with a thesis on the molecular genetics of familial hypertriglyceridaemias. He worked as a postdoctoral researcher in the lab of Prof. Daniel J. Rader at the University of Pennsylvania (Philadelphia, PA, USA) in 2012 and 2013 on the characterization of the SCARB1 P376L loss of function mutation, that resulted in the Science paper for which he is receiving the EAS Young Investigator Award for outstanding publications 2016. Since the end of 2013 Paolo Zanoni is pursuing a PhD in Integrative Molecular Medicine at the University of Zürich (Switzerland), under the supervision of Prof. Arnold von Eckardstein, with a focus on the discovery of new molecular players involved in hepatic lipoprotein endocytosis through high throughput screenings.

Receiving this prize Paolo Zanoni wishes especially to acknowledge the co-first authors of this paper Sumeet Khetarpal and Daniel B. Larach.

 


Mon 24 Apr

Presentation by Young Investigators Award winner Clinical Research: Paolo Zanoni

Rising Stars: Presentations by the winners of the EAS Young Investigator Awards for outstandings publications 2016

 

 


Pirkka-Pekka Laurila

Helsinki, Finland

Pirkka-Pekka Laurila, MD, PhD, conducted his doctoral research at the National Institute of Health and University of Helsinki, where he received his MD and has been teaching medical genetics. In his research into the pathogenesis of cardiovascular disease and metabolic traits, he has combined a number of approaches ranging from genome-wide association analyses to mechanistic studies in animal models. He has discovered new pathways leading low levels of HDL-C and impaired HDL composition, and recently, identified USF1 as a repressor of brown adipose tissue activity with low USF1 expression leading to beneficial lipid profile, reduced obesity and atherosclerosis. Currently, he is studying the effects of metabolism and aging on cardiometabolic traits at the École Polytechnique Fédérale de Lausanne in Switzerland in the laboratory of Prof. Johan Auwerx. He has previously received an ATVB Early Career Investigator Award by American Heart Association, and Young Investigator Awards by International Atherosclerosis Society and Finnish Atherosclerosis Society.


Mon 24 Apr

Presentation by Young Investigators Award winner Basic Research: Pirkka-Pekka Laurila

Rising Stars: Presentations by the winners of the EAS Young Investigator Awards for outstandings publications 2016